Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial

Autor: Marmur, Jonathan D., Mitre, Cristina A., Barnathan, Elliot, Cavusoglu, Erdal
Zdroj: In American Heart Journal 2006 152(5):876-881
Databáze: ScienceDirect